Minnesota SF 751: Prescription opioids label disclosures requirement

Status: Second reading (as of 2017-05-10)

State: Minnesota · Session: 2017-2018 · Bill: SF 751

Subjects: Consumer Protection, Drugs and Medicine, Health and Health Department, Human Services and Human Services Department

Sponsors: Eaton, Abeler, Cwodzinski, Kent, Rosen

View Minnesota SF 751 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.